Verdant PhytoMed — Appendices
A detailed monthly cash flow projection for Year 1 is available upon request and will be provided as part of the investor data room documentation.
Section 16 · Business Plan
Appendices
A detailed monthly cash flow projection for Year 1 is available upon request and will be provided as part of the investor data room documentation.
Appendix A: Glossary of Terms
| Term | Definition |
|---|---|
| API | Active Pharmaceutical Ingredient |
| B-BBEE | Broad-Based Black Economic Empowerment |
| CAGR | Compound Annual Growth Rate |
| CBD | Cannabidiol |
| COA | Certificate of Analysis |
| DALRRD | Department of Agriculture, Land Reform and Rural Development |
| EBITDA | Earnings Before Interest, Tax, Depreciation and Amortisation |
| EIA | Environmental Impact Assessment |
| EPC | Engineering, Procurement and Construction |
| EU-GMP | European Union Good Manufacturing Practice |
| FOB | Free on Board (Incoterms) |
| GACP | Good Agricultural and Collection Practice |
| GC-MS | Gas Chromatography–Mass Spectrometry |
| HPLC | High Performance Liquid Chromatography |
| IFRS | International Financial Reporting Standards |
| IRR | Internal Rate of Return |
| JSE | Johannesburg Stock Exchange |
| NPV | Net Present Value |
| SAHPRA | South African Health Products Regulatory Authority |
| SAPS | South African Police Service |
| THC | Tetrahydrocannabinol |
| WACC | Weighted Average Cost of Capital |
Appendix B: Detailed Monthly Cash Flow — Year 1
A detailed monthly cash flow projection for Year 1 is available upon request and will be provided as part of the investor data room documentation.
Appendix C: Letters of Intent
Copies of signed letters of intent from prospective offtake partners are available for review under non-disclosure agreement in the investor data room.
Appendix D: Management CVs
Detailed curriculum vitae for all directors, key management personnel, and advisory board members are available in the investor data room.
Appendix E: Facility Design Drawings
Preliminary architectural and engineering drawings for the greenhouse facility and GMP processing plant are available for review in the investor data room.
This document contains proprietary and confidential information. Distribution without written consent is prohibited.